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cluster 5 were resistant to metronidazole whereas 78% of
the strains in cluster 6 were susceptible to both antibiotics.
Conclusion: These results indicate that clinical Heli-
cobacter pylori strains in terms of antibiotic resistance are
highly diverse. It seems the characteristics of the resistant
and susceptible strains can be predicted by clustering of
strains using RAPD-PCR profiling.
doi:10.1016/j.ijid.2008.05.276
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Background: Pseudomonas aeruginosa (PA) is an impor-
tant nosocomial pathogen causing a wide spectrum of
infections and leading to substantial morbidity and mor-
tality. In order to apply optimal therapeutic guidelines
physicians must be aware of recent resistance surveillance,
and epidemiological data. The main objective was to deter-
mine antimicrobial susceptibility of PA isolates in order to
assist the guidelines for empirical regimens and infection
control measures.
Methods: From April 2003 - April 2007, 1446 PA iso-
lates were collected in Centro Hospitalar de Coimbra.
Nosocomial isolates (N= 907) and ambulatory ones (N = 539)
were obtained from sputum (41.2%), urine (24.2%), exu-
dates (14.2%), blood (4.6%) and other sources (15.8%).
They were identified with API32GN (BioMe´rieux) and
MicroScan WalkAway (Dadebehring) and susceptibility pat-
terns were determined with these panels. Susceptibilities to
Piperacillin (PIP), Piperacillin plus Tazobactam (TZP), Aztre-
onam (AZT), Ceftazidime (CAZ), Imipenem (IP), Meropenem
(MP), Amikacin (AMK), Gentamicin (GN), and Ciprofloxacin
(CIP) were guideline by CLSI.
Results: Overall, MP was the best agent (88.0%), followed
by TZP (87.6%), AMK (86.4%), PIP (85.2%), CAZ (82.5%), IP
(79.9%), AZT (79.5%), GN (69.2%) and CIP (66.3%). Nosoco-
mial isolates responded to TZP (82.6%), AMK (82.5%), MP
(81.7%), PIP (79.4%), CAZ (75.5%), AZT (71.4%), IP (70.9%),
GN (62.6%), and CIP (60.5%). Ambulatory isolates presented
susceptibility superior to 90%, except for GN (80.1%) and
CIP (76.1%). During these years the susceptibilities to most
important beta lactams (IP, MP and CAZ) had diminished;
activity of IP decreased 5.9%, CAZ 4.8%, and MP 3.6%.
Conclusion: Appropriate empirical treatments based on
knowledge of particular resistance patterns are important
determinants of the success of treatment, therefore stud-
ies of surveillance can be helpful in fight to control the
development and spread of resistance.
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Background: Several antibiotic combinations are being
used for treatment of brucellosis in endemic regions. The
purpose of this study was to evaluate the antibacterial sus-
ceptibility of several common antibiotics which are used for
treatment of brucellosis.
Methods: From May to October 2007, blood cultures from
26 cases of brucellosis were positive for brucella mellitensis.
Susceptibility testing were performed with using gen-
tamicin, streptomycin, ciprofloxacin, ofloxacin,doxycycline,
cotrimoxazole, rifampin and the results were recorded.
Results: All isolates were susceptible to gentamicin,
streptomycin, Ciprofloxacin, ofloxacin, doxycycline but
resistance to rifampin and Cotrimoxazole.
Conclusion: The results show that resistance of brucella
mellitensis to rifampin and cotrimoxazole are being devel-
oped in endemic regions. Attempts to find out a regimen
free of these agents are recommended.
doi:10.1016/j.ijid.2008.05.278
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Background: ESBL producing GNB causing blood stream
infections (BSI), skin and soft tissue (SSTI) and respiratory
tract infection (RTI) are widely prevalent in Indian medical
centers. We compared the in-vitro activity of five com-
monly used antimicrobials to treat such infections against
the recently introduced carbapenem - ertapenem (ERT).
Methods: From a collection of 776 clinically signif-
icant isolates prospectively collected (2005—2007) from
seven medical centers, 238 GNB isolates (Escherichia coli
[EC], = 122, Klebsiella spp. [KS], = 107 and Enterobac-
ter spp. [ES] = 9) obtained from RTI (n = 75), BSI (n = 74),
SSTI (n = 70) and urinary tract (n = 19) were tested. ESBL
screen was performed by disc diffusion using cefotaxime
(CTX) and ceftazidime (CZD), confirmed using CTX and
CZD discs with and without clavulanic acid and Etest
ESBL strips. Antimicrobial resistance to levofloxacin (LEV),
amikacin (AMK), piperacillin/tazobactam (P/T), imipenem
(IMP), meropenem (MER) and ERT was determined by agar
dilution and Etest. Isolates were consideredmulti-drug resis-
tant (MDR), if resistant to >2 classes. Polymerase Chain
Reaction (PCR) was done to determine beta lactamases
(bla)TEM, SHV and CTX-M among 120 isolates.
